Table 2.
Repeated ANOVA analysis at the clinic level.
| Variable | Phase A | Phase B | Phase C | p-value that the 3 phases are different | p-value that Phase A = Phase B | p-value that Phase A = Phase C | p-value that Phase B = Phase C value |
|---|---|---|---|---|---|---|---|
| Hb (g/dL)1,2 | 9.9 (0.2) | 10.2 (0.3) | 10.3 (0.1) | 0.032 | 0.022 | 0.011 | 0.323 |
| TSAT (%)1,2 | 36.2 (3.5) | 28.5 (1.1) | 29.8 (1.4) | 0.009 | 0.004 | 0.008 | 0.279 |
| Ferritin (mcg/L)1,2,3 | 1005 (45) | 885 (57) | 765 (83) | 0.008 | 0.023 | 0.003 | 0.024 |
| Serum iron (mcg/dL)1,2 | 82 (9) | 65 (3) | 69 (3) | 0.016 | 0.007 | 0.012 | 0.278 |
| TIBC (mcg/dL)1,2 | 225 (3) | 230 (2) | 232 (2) | 0.021 | 0.017 | 0.008 | 0.216 |
| Aranesp (mcg) | 97 (17) | 95 (14) | 90 (12) | 0.532 | 0.691 | 0.279 | 0.444 |
| Venofer (mg)1,2 | 146 (56) | 61 (49) | 68 (30) | 0.068 | 0.025 | 0.031 | 0.761 |
| Triferic (mg) | NA | 88 (4) | 87 (5) | NA | NA | NA | NA |
| Venofer + Triferic (mg) | 146 (56) | 145 (48) | 150 (29) | 0.4891 | 0.966 | 0.225 | 0.804 |
1indicates a statistically significant difference between Phase A and Phase B.
2indicates a statistically significant difference between Phase A and Phase C.
3indicates a statistically significant difference between Phase B and Phase C.